Nimotas P (60 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Intas Laboratories Pvt Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Nimesulide. This drug comes in the form of Suspension. The general packing available for this medicine consists of 60 ml and is priced at Rs 27 (arround $0.378 US Dollar)
Generic (Salt) Combination :
(Paracetamol+ Nimesulide)
Pharma Company :
Intas Laboratories Pvt Ltd
Brand Label :
Nimotas P (60 ml)
Preparation Type :
Suspension
Single Dose :
5 ml
Composition (Fixed-Dose Combination) :
Nimesulide-50 mg
Paracetamol-125 mg
Pack Size/Qty/Vol :
60 ml
Price Unit :
Rs 2.25 INR (arround $0.0315 US Dollar)
Price Pack :
Rs 27 INR (arround $0.378 US Dollar)
Drug details for Nimotas P (60 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Nimotas P (60 ml) are :
Nimesulide-50 mg
Paracetamol-125 mg
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Nimesulide Indication (Prescribed for or used as): Analgesic and antipyretic. Rheumatoid arthritis, osteoarthritis, other degenerative joint disorders. Musculo skeletal disorders. Thrombophlebitis.
For more details on Nimesulide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Nimesulide..
Nimotas P (60 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 60 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Nimotas P (60 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Nimesulide-50 mg Paracetamol-125 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.